Butterfield, D. ., Gnjec, A. ., Poon, H. ., Castegna, A. ., Pierce, W. ., Klein, J. ., & Martins, R. . (2006). Redox proteomics identification of oxidatively modified brain proteins in inherited Alzheimer’s disease: an initial assessment. Journal of Alzheimer’s Disease : JAD, 10(4), 391-7. https://doi.org/10.3233/jad-2006-10407
A Castegna
First name:
A
Last name:
Castegna
Butterfield, D. ., Boyd-Kimball, D. ., & Castegna, A. . (2003). Proteomics in Alzheimer’s disease: insights into potential mechanisms of neurodegeneration. Journal of Neurochemistry, 86(6), 1313-27. https://doi.org/10.1046/j.1471-4159.2003.01948.x
Butterfield, D. ., & Castegna, A. . (2003). Proteomic analysis of oxidatively modified proteins in Alzheimer’s disease brain: insights into neurodegeneration. Cellular and Molecular Biology (Noisy-Le-Grand, France), 49(5), 747-51.
Butterfield, D. ., & Castegna, A. . (2003). Proteomics for the identification of specifically oxidized proteins in brain: technology and application to the study of neurodegenerative disorders. Amino Acids, 25(3-4), 419-25. https://doi.org/10.1007/s00726-003-0027-7
Castegna, A. ., , Klein, J. ., Lynn, B. ., Wang, Y. ., Osaka, H. ., … Butterfield, D. . (2004). Proteomic analysis of brain proteins in the gracile axonal dystrophy (gad) mouse, a syndrome that emanates from dysfunctional ubiquitin carboxyl-terminal hydrolase L-1, reveals oxidation of key proteins. Journal of Neurochemistry, 88(6), 1540-6. https://doi.org/10.1046/j.1471-4159.2003.02288.x
Castegna, A. ., Lauderback, C. ., Mohmmad-Abdul, H. ., & Butterfield, D. . (2004). Modulation of phospholipid asymmetry in synaptosomal membranes by the lipid peroxidation products, 4-hydroxynonenal and acrolein: implications for Alzheimer’s disease. Brain Research, 1004(1-2), 193-7. https://doi.org/10.1016/j.brainres.2004.01.036 (Original work published 2004)
Drake, J. ., Petroze, R. ., Castegna, A. ., Ding, Q. ., Keller, J. ., Markesbery, W. ., … Butterfield, D. . (2004). 4-Hydroxynonenal oxidatively modifies histones: implications for Alzheimer’s disease. Neuroscience Letters, 356(3), 155-8. https://doi.org/10.1016/j.neulet.2003.11.047 (Original work published 2004)
Poon, H. ., Castegna, A. ., Farr, S. ., , Lynn, B. ., Banks, W. ., … Butterfield, D. . Quantitative proteomics analysis of specific protein expression and oxidative modification in aged senescence-accelerated-prone 8 mice brain. Neuroscience, 126(4), 915-26. https://doi.org/10.1016/j.neuroscience.2004.04.046 (Original work published 2004)
Boyd-Kimball, D. ., Castegna, A. ., Sultana, R. ., Poon, H. ., Petroze, R. ., Lynn, B. ., … Butterfield, D. . (2005). Proteomic identification of proteins oxidized by Abeta(1-42) in synaptosomes: implications for Alzheimer’s disease. Brain Research, 1044(2), 206-15. https://doi.org/10.1016/j.brainres.2005.02.086 (Original work published 2005)